The present invention is directed to stable formulations comprising therapeutically effective amount of anidulafungin and buffering agent selected from glutamic, picolinic and benzoic acid.La présente invention concerne des formulations stables comprenant une quantité thérapeutiquement efficace danidulafungine et un agent tampon choisi parmi lacide glutamique, picolinique et benzoïque.